{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:07:33Z","timestamp":1793725653352,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T00:00:00Z","timestamp":1422230400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/1475-2891-14-13","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:44:37Z","timestamp":1434613477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients"],"prefix":"10.1186","volume":"14","author":[{"given":"Inayat U","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rooh Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil Ur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,26]]},"reference":[{"key":"879_CR1","doi-asserted-by":"publisher","DOI":"10.1596\/0-8213-3856-0","volume-title":"Medicinal plants: rescuing a global heritage","author":"J Lambert","year":"1997","unstructured":"Lambert J, Srivastava J, Vietmeyer N World Bank Technical Paper No. 355. In Medicinal plants: rescuing a global heritage. 1818 H Street, N.W. Washington, D.C. 20433, U.S.A; 1997."},{"key":"879_CR2","volume-title":"J Diab Res","author":"SI Rizvi","year":"2013","unstructured":"Rizvi SI, Mishra N: Traditional Indian medicines used for the management of diabetes Mellitus.J Diab Res 2013. doi:10.1155\/2013\/712092"},{"key":"879_CR3","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.2105\/AJPH.92.10.1582","volume":"92","author":"G Bodeker","year":"2002","unstructured":"Bodeker G, Kronenberg F: A Public health agenda for traditional, complementary, and alternative medicine.Am J Publ Health 2002, 92:1582\u201391. 10.2105\/AJPH.92.10.1582","journal-title":"Am J Publ Health"},{"key":"879_CR4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000497551","volume":"11","author":"C Garau","year":"2003","unstructured":"Garau C, Cummings E, David AP, Jaipaul S: Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: a mini review.Int J Diab Metabol 2003, 11:46\u201355.","journal-title":"Int J Diab Metabol"},{"key":"879_CR5","first-page":"179","volume":"1","author":"K Abascal","year":"2005","unstructured":"Abascal K, Yarnell E: Using bitter melon to treat diabetes.J Altern Complement Med 2005, 1:179\u201384.","journal-title":"J Altern Complement Med"},{"key":"879_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1023\/B:MCBI.0000028743.75669.ab","volume":"261","author":"E Cummings","year":"2004","unstructured":"Cummings E, Hundal HS, Wackerhage H, Hope M, Belle M, Adeghate E, et al.: Momordica Charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes.Mol Cell Biochem 2004, 261:99\u2013104.","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"879_CR7","first-page":"919","volume":"68","author":"N Akhtar","year":"2011","unstructured":"Akhtar N, Khan BA, Majid A, Khan S, Mahmood T: Pharmaceutical and biopharmaceutical evaluation of extracts from different plant parts of indigenous origin for their hypoglycemic responses in rabbits.Acta Pol Pharm 2011,68(6):919\u201325.","journal-title":"Acta Pol Pharm"},{"key":"879_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1023\/B:MCBI.0000028738.95518.90","volume":"261","author":"I Ahmed","year":"2004","unstructured":"Ahmed I, Cummings E, Sharma AK, Adeghate E, Singh J: Beneficial effects and mechanism of action of Momordica Charantia fruit juice in the treatment of streptozotocin-induced diabetes mellitus in rats.Mol Cell Biochem 2004, 261:63\u201370.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"879_CR9","first-page":"101","volume":"29","author":"N Singh","year":"2008","unstructured":"Singh N, Gupta M, Sirohi P: Varsha: Effects of alcoholic extract of Momordica Charantia (Linn.) whole fruit powder on the pancreatic islets of alloxan diabetic albino rats.J Environ Biol 2008,29(1):101\u20136.","journal-title":"J Environ Biol"},{"key":"879_CR10","first-page":"227","volume":"17","author":"JA Ojewole","year":"2006","unstructured":"Ojewole JA, Adewole SO, Olayiwola G: Hypoglycemic and hypotensive effects of Momordica Charantia Linn. (Cucurbitaceae) whole plant aqueous extract in rats.Cardiovasc 2006, 17:227\u201332.","journal-title":"Cardiovasc"},{"key":"879_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0378-8741(03)00184-3","volume":"88","author":"J Virdi","year":"2003","unstructured":"Virdi J, Sivakami S, Shahani S, Suthar AC, Banavalikar MM, Biyani MK: Antihyperglycemic effects of three extracts from Momordica Charantia.J Ethnopharmacol 2003, 88:107\u201311. 10.1016\/S0378-8741(03)00184-3","journal-title":"J Ethnopharmacol"},{"key":"879_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1042\/bj2920267","volume":"292","author":"BA Shibib","year":"1993","unstructured":"Shibib BA, Khan LA, Rahman R: Hypoglycemic activity enzymes glucose-6-phosphatase and fructose-1\u20136-bisphosphatase and elevation of both liver and red cell shunt enzyme glucose-6-phosphate dehydrogenase.Biochem J 1993, 292:267\u2013720.","journal-title":"Biochem J"},{"issue":"6","key":"879_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3177\/jnsv.53.482","volume":"53","author":"T Uebanso","year":"2007","unstructured":"Uebanso T, Arai H, Taketani Y, Fukaya M, Yamamoto H, Mizuno A, et al.: Extracts of Momordica Charantia suppress postprandial hyperglycemia in rats.J Nutr Sci Vitaminol 2007,53(6):482\u20136. 10.3177\/jnsv.53.482","journal-title":"J Nutr Sci Vitaminol"},{"issue":"3","key":"879_CR14","first-page":"327","volume":"48","author":"J Jeong","year":"2008","unstructured":"Jeong J, Lee S, Hue J, Lee K, Nam SY, Yun YW, et al.: Effect of bitter melon on antidiabetic activity in C57 BL\/6J db\/db mice.Korean J Vet Res 2008,48(3):327\u201336.","journal-title":"Korean J Vet Res"},{"issue":"31","key":"879_CR15","first-page":"5004","volume":"9","author":"M Abdollah","year":"2010","unstructured":"Abdollah M, Zuki ABZ, Goh YM, Rezaeizadeh A, Noordin MM: The effects of bitter melon on the liver in STZ induced diabetes in neonatal rats.Afr J Biotechnol 2010,9(31):5004\u201312.","journal-title":"Afr J Biotechnol"},{"key":"879_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/1874104501105010070","volume":"5","author":"J Singh","year":"2011","unstructured":"Singh J, Cumming E, Manoharan G, Kalasz H, Adeghate E: Medicinal chemistry of the antidiabetic effect of Momordica Charantia: active constituents and modes of action.Open Med Chem J 2011, 5:70\u20137. 10.2174\/1874104501105010070","journal-title":"Open Med Chem J"},{"key":"879_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1472-6882-10-34","volume":"10","author":"PV Nerurkar","year":"2010","unstructured":"Nerurkar PV, Lee YK, Nerurkar VR: Bitter melon inhibits primary human adipocyte differentiation by modulating adipogenic genes.BMC Complement Altern Med 2010, 10:34. 10.1186\/1472-6882-10-34","journal-title":"BMC Complement Altern Med"},{"key":"879_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/jmf.2010.0010","volume":"14","author":"V Gadang","year":"2011","unstructured":"Gadang V, Gilbert W, Hettiararchchy N, Horax R, Katwa L, Devareddy L: Dietary bitter melon seed increases peroxisome proliferator activated receptor \u03b3-gene expression in adipose tissue, down regulates the nuclear factor-kB expression and alleviates the symptoms associated with metabolic syndrome.J Med Food 2011, 14:86\u201393. 10.1089\/jmf.2010.0010","journal-title":"J Med Food"},{"key":"879_CR19","first-page":"1206","volume":"64","author":"FE Wehash","year":"2012","unstructured":"Wehash FE, Abpo-Ghanema II, Saleh RM: Some physiological effects of Momordica Charantia and Trigonella foenum-graecum extracts in diabetic rats as compared with cidophage\u00ae.Proc World Acad Sci Eng Tech 2012, 64:1206\u201314.","journal-title":"Proc World Acad Sci Eng Tech"},{"key":"879_CR20","first-page":"11","volume":"25","author":"N Ahmad","year":"1999","unstructured":"Ahmad N, Hassan MR, Halder H, Bennoor KS: Effect of Momordica Charantia (Karella) extracts on fasting and postprandial serum glucose in NIDDM patients.Bangladesh Med Res Counc Bull 1999, 25:11\u20133.","journal-title":"Bangladesh Med Res Counc Bull"},{"issue":"4","key":"879_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ptr.2650070405","volume":"7","author":"Y Srivastava","year":"1993","unstructured":"Srivastava Y, Venkatakrishna BH, Verma Y, Venkaiah K, Raval BH: Antidiabetic and adaptogenic properties of Momordica Charantia extract: An experimental and clinical evaluation.Phytother Res 1993,7(4):285\u20139. 10.1002\/ptr.2650070405","journal-title":"Phytother Res"},{"key":"879_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jep.2010.12.045","volume":"134","author":"A Fuangchan","year":"2011","unstructured":"Fuangchan A, Sonthisombat P, Seubnukarn T, Chanouan R, Chotchaisuwat P, Sirigulsatien V, et al.: Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.J Ethnopharm 2011, 134:422\u20138. 10.1016\/j.jep.2010.12.045","journal-title":"J Ethnopharm"},{"key":"879_CR23","first-page":"27","volume-title":"Multicultural handbook of Food, Nutrition and Dietetics","author":"A Thaker","year":"2012","unstructured":"Thaker A, Barton A: Multicultural handbook of Food, Nutrition and Dietetics. 9600 Garsington Road, Oxford, OX4 2DQ, UK: Willey Blackwell; 2012:27\u20138."},{"issue":"3","key":"879_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.seppur.2005.11.037","volume":"52","author":"J Pitipanapong","year":"2007","unstructured":"Pitipanapong J, Chitprasert S, Goto M, Jiratchariyakul W, Sasaki M, Shotipruk A: New approach for extraction of charantin from Momordica Charantia with pressurized liquid extraction.Sep Purif Technol 2007,52(3):416. 10.1016\/j.seppur.2005.11.037","journal-title":"Sep Purif Technol"},{"key":"879_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.foodchem.2013.10.025","volume":"148","author":"N Zhi Xiang","year":"2014","unstructured":"Zhi Xiang N, Chua KH, Kuppusamy UR: Proteomic analysis of heat treated bitter gourd (Momordica Charantia L. var. Hong Kong Green) using 2D-DIGE.Food Chem 2014, 148:155\u201361.","journal-title":"Food Chem"},{"issue":"2","key":"879_CR26","first-page":"241","volume":"48","author":"A Tongia","year":"2004","unstructured":"Tongia A, Tongia SK, Dave M: Phytochemicalm determination and extraction of Momordica charantia fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in diabetes mellitus (NIDDM).Indian J Physiol Pharmacol 2004,48(2):241\u20134.","journal-title":"Indian J Physiol Pharmacol"},{"key":"879_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jclinepi.2006.07.009","volume":"60","author":"AM Dans","year":"2007","unstructured":"Dans AM, Villarruz MV, Jimeno CA, Javelosa MA, Chua J, Bautista R, et al.: The effect of Momordica Charantia capsule preparation on glycemic control in type2 diabetes mellitus needs further studies.J Clin Epidemiol 2007, 60:554\u20139. 10.1016\/j.jclinepi.2006.07.009","journal-title":"J Clin Epidemiol"},{"key":"879_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1042\/cs0830593","volume":"83","author":"MA Crook","year":"1992","unstructured":"Crook MA, Tutt P: Serum sialic acid concentration in patients with hypertriglyceridemia showing the Frederickson IIb phenotype.Clin Sci 1992, 83:593\u20135.","journal-title":"Clin Sci"},{"issue":"8","key":"879_CR29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2337\/diacare.18.8.1100","volume":"18","author":"JC Pickup","year":"1995","unstructured":"Pickup JC, Mattock MB, Crook MA, Chusney GD, Burt D, Fitzgerald AP: Serum sialic acid concentration and coronary heart disease in NIDDM.Diabetes Care 1995,18(8):1100\u20133. 10.2337\/diacare.18.8.1100","journal-title":"Diabetes Care"},{"key":"879_CR30","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.annepidem.2003.09.017","volume":"14","author":"MW Knuiman","year":"2004","unstructured":"Knuiman MW, Watts GF, Divitini ML: Is sialic acid an independent risk factor for cardiovascular disease. A 17 year follow-up study in Busselton, Western Australia.Ann Epidemiol 2004, 14:627\u201332. 10.1016\/j.annepidem.2003.09.017","journal-title":"Ann Epidemiol"},{"key":"879_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0022-2143(02)00025-2","volume":"140","author":"SS Gokmen","year":"2002","unstructured":"Gokmen SS, Kilicli G, Folsom AR, Ozeelik F, Ture M, Gulen S: Association between serum total and lipid bound sialic acid concentration and the severity of coronary atherosclerosis.J Lab Clin Med 2002, 140:110\u20138. 10.1016\/S0022-2143(02)00025-2","journal-title":"J Lab Clin Med"},{"issue":"4","key":"879_CR32","first-page":"1019","volume":"1","author":"F Tayyab","year":"2012","unstructured":"Tayyab F, Lal SS, Mishra M, Kumar U: Medicinal plants and its impact on diabetes.World J Pharmaceutical Res 2012,1(4):1019\u201346.","journal-title":"World J Pharmaceutical Res"},{"key":"879_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1056-8727(96)00092-X","volume":"11","author":"M Laakso","year":"1997","unstructured":"Laakso M: Morbidity and mortality in NIDDM: lipoproteins and coronary heart disease in NIDDM.J Diabetes Complications 1997, 11:137\u201341. 10.1016\/S1056-8727(96)00092-X","journal-title":"J Diabetes Complications"},{"issue":"9921","key":"879_CR34","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","volume":"383","author":"SS Mahmood","year":"2014","unstructured":"Mahmood SS, Levy D, Vasan RS, Wang TJ: The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.Lancet 2014,383(9921):999\u20131008. 10.1016\/S0140-6736(13)61752-3","journal-title":"Lancet"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-14-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2891-14-13\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-14-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T18:29:12Z","timestamp":1748456952000},"score":1,"resource":{"primary":{"URL":"http:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/1475-2891-14-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["879"],"URL":"https:\/\/doi.org\/10.1186\/1475-2891-14-13","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,26]]},"article-number":"13"}}